Eye Scans Might Help Determine Heart Health Risk, Experts Say

The eyes are the windows to the soul, the old saying goes.

They also might serve as a window into a person’s heart health, a new study adds.

The tiny blood vessels in a person’s eyes can be used to predict their risk of heart disease, as well as whether they’re aging at an accelerated rate, researchers reported Oct....

Clinical Trial Finds Ketamine Not Effective For Depression

Ketamine might not be effective in treating depression, new clinical trial results reveal.

Ketamine infusions added to standard depression care did nothing for people hospitalized with the mood disorder, researchers reported Oct. 22 in JAMA Psychiatry.

“Our initial hypothesis was that repeated ketamine infusions for pe...

Women Struggle On Lung Transplant List, Experts Say

Women are less likely than men to find a donor lung, despite new systems to make organ allocation fairer, a new study says.

Women were 32% less likely than men to receive a lung implant before the reforms went into effect in March 2023, researchers reported recently in the Annals of Thoracic Surgery.

But afterward, they were...

CTE Not Likely Among People With Few Concussions, Experts Report

Folks who’ve suffered one or two concussions at some point shouldn’t worry about developing chronic traumatic encephalopathy (CTE), a new study has concluded.

CTE is more common in people who experience many repeated head impacts, like the football players in whom the disorder was first identified, researchers recently reported...

Cunning, Manipulative People Use Touch As A Weapon, Study Says

A friendly clasp on the shoulder. A comforting hug. Holding hands.

All these can be dangerous in the wrong hands, a new study reports.

Manipulative and narcissistic people are more likely to use touch in a calculating manner to influence their partners, researchers report in the journal Current Psychology.

“What&...

New Nonhormonal Drug Approved to Treat Menopause Symptoms

The U.S. Food and Drug Administration (FDA) has approved a new nonhormonal treatment to help women manage menopause symptoms such as hot flashes and night sweats.

Elinzanetant (Lynkuet), a once-daily pill, is expected to be available within weeks.

These uncomfortable symptoms affect up to 80% of women during menopause and can last a ...